Dimensional Fund Advisors’s AYTU BioPharma AYTU Stock Holding History

Dimensional Fund Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.5K	Buy	45,326 +1,741	+4%	+$4.11K	﹤0.01%	3142
2026 Q1	$119K	Buy	43,585 +8,222	+23%	+$21K	﹤0.01%	3104
2025 Q4	$91.9K	Buy	35,363 +4,399	+14%	+$9.87K	﹤0.01%	3160
2025 Q3	$58.2K	Buy	+30,964	New	+$71.6K	﹤0.01%	3232
2025 Q1	–	Sell	-10,926	Closed	-$18.2K	–	3328
2024 Q4	$18.2K	Sell	10,926 -10,906	-50%	-$19.9K	﹤0.01%	3327
2024 Q3	$51.3K	Sell	21,832 -1,719	-7%	-$4.45K	﹤0.01%	3297
2024 Q2	$68.5K	Buy	23,551 +8,311	+55%	+$25.1K	﹤0.01%	3288
2024 Q1	$46.3K	Buy	+15,240	New	+$43.6K	﹤0.01%	3337
2023 Q2	–	Sell	-47,263	Closed	-$106K	–	3485
2023 Q1	$106K	Buy	+47,263	New	+$138K	﹤0.01%	3294

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors's AYTU Position: Q2 2026 in Review

Dimensional Fund Advisors increased its AYTU BioPharma (AYTU) stake by 4% in Q2 2026, buying an estimated $4.11K and bringing the position to 45,326 shares worth $97.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

Dimensional Fund Advisors first reported a position in AYTU in Q1 2023 and has held it in 9 quarters since. The position peaked at $119K in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

Dimensional Fund Advisors held 45,326 shares of AYTU BioPharma worth $97.5K as of Q2 2026.
Dimensional Fund Advisors bought 1,741 AYTU BioPharma shares in Q2 2026, an estimated $4.11K.
AYTU BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3142 holding.
Dimensional Fund Advisors first reported a position in AYTU BioPharma in Q1 2023 and has held it in 9 quarters since.
Dimensional Fund Advisors's AYTU BioPharma position peaked at $119K in Q1 2026.
38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.